Internal Server Error

About BOLD

BOLD is a venture capital firm located in Clichy, France. As of Jun 2026, BOLD is an active investor, having invested in 24 companies, with 3 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Retail to Consumer and High Tech. Most recently it participated in the $***** Post IPO round of OliX Pharmaceuticals Overall, BOLD portfolio has seen 3 IPOs and 2 acquisitions including key companies like OliX Pharmaceuticals, Global Bioenergies and Slick. A lot of funds co-invest with BOLD, with names like Touch Capital sharing a substantial percentage of its portfolio. BOLD has team of 6 people including 2 partners.
Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 2 more
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months

BOLD's List of Top Investments

BOLD has a portfolio of 24 companies. Their most notable investments are in Replika and BORNTOSTANDOUT.Their portfolio spans across France, United States, South Korea and 5 more locations. They have invested in Retail, Consumer, High Tech and 14 other sectors, across stages such as Series A, Seed  and 2 more. Here is the list of top investments by BOLD:
Platform offering multi-category skincare products. It offers a wide range of science-backed solutions, including face and body care products, lip balms, cleansers, serums, and sunscreens. The brand also provides specialized kits such as an oily skin kit and a skin radiance routine kit. Its products cater to various skin types and concerns, including hydration, brightening, and anti-aging.

Key facts about Deconstruct

  • Founded Year: 2020
  • Location: Bengaluru (India)
  • Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2026
  • Valuation: $*****
  • Stage: Series A
  • Total Funding till date: $10.4M
  • Employee Count: 74 as on Aug 31, 2025
  • Investors: Verlinvest, Kalaari Capital and 16 Others
  • Latest Funding Round: Series A, Dec 24, 2024, $*****
  • Highlight: Editors' Pick
Provider of AI-powered advertising solutions for in-content and social media. The company offers tools for advertisers and publishers to integrate brand messaging within digital content. It transforms social media content into advertisements and places virtual product placements within relevant scenes. The company aims to deliver advertising experiences that are more natural for viewers.

Key facts about Rembrand

  • Founded Year: 2022
  • Location: Palo Alto (United States)
  • Stage: Series B
  • Total Funding till date: $68.5M
  • Employee Count: 74 as on Sep 30, 2026
  • Investors: Naver, Greycroft and 9 Others
  • Latest Funding Round: Series B, Nov 21, 2025, $*****
  • Highlight: Editors' Pick
Internet-first brand of multi category beauty care products. Its catalog includes body wash, hair creams, shampoo, hair gel, lip balms, skincare products, and more. The company claims to offer natural, vegan, and cruelty-free beauty products.

Key facts about Arata

  • Founded Year: 2017
  • Location: Delhi (India)
  • Annual Revenue: ₹50 - ₹100 Cr as on Mar 31, 2025
  • Valuation: $*****
  • Stage: Series A
  • Total Funding till date: $8.91M
  • Employee Count: 89 as on Jul 31, 2025
  • Investors: Beeline Impex, Unilever Ventures and 41 Others
  • Latest Funding Round: Series A, Sep 03, 2024, $*****
  • Highlight: Editors' Pick
Developer of RNAi therapeutics for dermal, ophthalmic, and pulmonary diseases. Its drug pipeline includes OLX101 for the treatment of Skin Scar (licensed out to Huge Inc.), OLX201 for the treatment of Lung fibrosis, OLX301 for the treatment of Wet AMD/Retinal Fibrosis, OLX701 for liver fibrosis. Other products include OLX102 for skin whitening and OLX105 to get rid of wrinkles. The company's technology is based on three types of RNA: Small interfering RNA (siRNA), Asymmetric siRNA (siRNA), and Cell-penetrating asymmetric siRNA (cp-siRNA).

Key facts about OliX Pharmaceuticals

Internet first brand offering hair removal products for women. Its offering includes razor, shave pillow, blades, blade bin, and more. It also offers razor holders.

Key facts about hanni

BOLD's Investments by Stage

BOLD has made 10 investments in Series A stage with an average round size of $12.2M, 8 investments in Seed stage with an average round size of $5M, 2 investments in Post IPO stage with an average round size of $44.6M and 2 investments in Series B stage with an average round size of $24.8M.
Here are BOLD's investments by stage:
Stage of entry
No. of Investments
Series A
10
Seed
8
Post IPO
2
Series B
2
Breakdown of BOLD's investments by stage of entrySeries A (10)Seed (8)
Note: We have considered here, only first round of investments

BOLD's Investments by Sector

BOLD has a diverse portfolio, with companies operating in the Consumer, Consumer Goods, Retail, High Tech and Life Sciences. Notably, it has invested in 18 Tech companies, 11 Consumer (B2C) companies, 8 Enterprise (B2B) companies and at least 3 companies focusing on Software.
Here are BOLD's investments by sector:
Sector
No. of Investments
Consumer
10
Consumer Goods
9
Retail
9
High Tech
5
Life Sciences
4
Others
22
Breakdown of BOLD's investments by sectorsConsumer (10)Consumer Goods (9)
Note: We have considered here, only first round of investments

BOLD's Investments by Geography

BOLD has made most investments in United States (6), followed by France where it has made 5 investments.
Here are BOLD's investments by geography:
Country
No. of Investments
United States
6
France
5
South Korea
4
India
3
Switzerland
2
Others
2
Breakdown of BOLD's investments by countriesUnited States (6)France (5)
Note: We have considered here, only first round of investments

BOLD's recent investments

BOLD has made 3 investments in 2026 so far. OliX Pharmaceuticals and hanni are the latest among them.
Here are the most recent investments by BOLD:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jun 02, 2026
South Korea
Post IPO
4638
Apr 17, 2026
United States
Series A
7413
-
Mar 24, 2026
India
Series A
4471
Aug 26, 2025
United States
Series B
6497
Feb 18, 2025
South Korea
Series A
3988

IPOs and Publicly Listed companies in BOLD's Portfolio

3 of BOLD's portfolio companies have become public. OliX Pharmaceuticals got listed on the Korea Exchange (KRX), in Jul 2018 at marketcap of $210M and Carbios got listed on the Euronext Exchange (Euronext).
Here are BOLD's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jul 20, 2018
Jun 02, 2026
Post IPO
4064
Dec 19, 2013
Jun 25, 2019
Post IPO
2089
Jun 09, 2011
-
-
1839

Acquired companies in BOLD's Portfolio

2 companies from BOLD's portfolio have been acquired. The most recent acquisition was Slick in Mar 2026 by DaySmart for $*****.
Here are BOLD's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 31, 2026
-
-
4471
Jan 10, 2024
Mar 24, 2021
Seed
4654

Team profile of BOLD

BOLD has a team of 6 members including 2 Partners and 2 Principals located in France. BOLD's team does not sit on the board of any company as of now.
Here is a list of all team members in BOLD:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Paris
-
-
Partner
France
-
-
Principal
Paris
-
-
Principal
France
-

Co-investors of BOLD

Over the past 8 years, 128 investors have co-invested in BOLD's portfolio companies. This includes funds and angels.

  • Invested before BOLD: Europa, Kalaari Capital and 77 others have invested in rounds before BOLD. There are 2 companies where Europa has invested before BOLD and 1 company where Kalaari Capital has invested before BOLD.
  • Top Co-investors of BOLD: 43 investors entered a company along with BOLD. These include investors like Touch Capital (2 companies).
  • Invested after BOLD: A total of 6 investors have invested in BOLD's portfolio after their investments. Top Investors include INX International Ink (1 company), EDBI (1 company) and Wealthberry (1 company).

Recent News related to BOLD

•
Autret Joins L’Oréal’s VC Fund BOLDGlobal CosmeticNews•Sep 03, 2025•BOLD
View all news related to BOLD

FAQs about BOLD

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford